136309-62-1 Usage
Derivative of benzoic acid
2-(2-chloro-5-thienoyl)benzoic acid is derived from benzoic acid, which means it is a modified form of benzoic acid with additional functional groups.
Contains a chloro and thiophene group
The compound has a chloro (-Cl) and a thiophene group in its structure, which contribute to its unique properties and reactivity.
Potential building block for synthesis of pharmaceuticals and agrochemicals
2-(2-chloro-5-thienoyl)benzoic acid can be used as a starting material for the synthesis of various pharmaceuticals and agrochemicals due to its unique structure and reactivity.
Used as an intermediate in production of dyes, pigments, and other organic compounds
The compound is also used as an intermediate in the production of various organic compounds, including dyes and pigments.
Potential for biological and pharmacological activities
The presence of the chloro and thiophene groups in the compound's structure may contribute to its potential for various biological and pharmacological activities, making it of interest for research and development in the medicinal and agricultural fields.
Check Digit Verification of cas no
The CAS Registry Mumber 136309-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,3,0 and 9 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 136309-62:
(8*1)+(7*3)+(6*6)+(5*3)+(4*0)+(3*9)+(2*6)+(1*2)=121
121 % 10 = 1
So 136309-62-1 is a valid CAS Registry Number.
136309-62-1Relevant articles and documents
Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-imidazolyl)alkyl]- 1(2H)-phthalazinones
Yamaguchi,Kamei,Koga,Akima,Kuroki,Ohi
, p. 4052 - 4060 (2007/10/02)
A number of 4-substituted 2-[ω-(1-imidazolyl)alkyl]-1(2H)-phthalazinones were synthesized in order to develop agents possessing both thromboxane A2 synthetase inhibitory and bronchodilatory activities. The pharmacological evaluation of these compounds disclosed that they have both activities to various extents. Both activities were slightly dependent on the length of the 2-substituents and largely affected by the nature of the 4-substituents. Compounds bearing phenyl and thienyl groups exhibited relatively high and well-rounded activities. Among these compounds, 12j and 15f were found to be the most effective agents having well-rounded activities in vitro and in vivo. Introduction of a carboxyl group reduced both activities contrary to our expectation. 4-(3-Pyridyl)phthalazinone 18b was of particular interest because of unexpectedly high in vivo activities in spite of an absence of significant in vitro activities.
